Preview Perhaps one fourth of patients with schizophrenia respond only partially to standard neuroleptic therapy. Until recently, the only pharmacologic option for such patients was adjunctive treatment with other psychotropic drugs. Now two newer drugs-clozapine and risperidone-offer hope to patients with treatment-resistant schizophrenia. This article provides an up-to-date look at effective treatment of this troubling disorder.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00325481.1995.11946077 | DOI Listing |
Publication Analysis
Top Keywords
chronic schizophrenia
4
schizophrenia preview
4
preview fourth
4
fourth patients
4
patients schizophrenia
4
schizophrenia respond
4
respond partially
4
partially standard
4
standard neuroleptic
4
neuroleptic therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!